The results of this study support the view that tau pathology, and not just PrP, contributes significantly to both the psychiatric and the motor symptoms that characterize the phenotype of GSS PRNP F198S and that the different clinical phenotypes of GSS PRNP F198S and AD correlate with the specific pattern of tau anatomical distribution seen in each disease. Here, MAPT is linked to Alzheimer disease.